Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 174

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Serum oestradiol and oestrogen‐receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males

Ongphiphadhanakul, B., Rajatanavin, R., Chanprasertyothin, S., Piaseu, N., Chailurkit, L.·1998·Clinical Endocrinology

Abstract

OBJECTIVES: The physiological effects of oestrogens on bone in men were largely unanticipated until recently, when oestrogen deficiency in males with aromatase deficiency and oestrogen resistance was found to cause osteoporosis and delayed fusion of epiphyses despite sufficient serum testosterone. This raises the possibility that in normal men oestrogens rather than androgens are of physiological importance in bone maturation. In the present study, we examined the association of serum oestradiol (E2) compared to that of free testosterone (FT) with bone mineral density (BMD) in normal men. The effect of oestrogen receptor (ER) gene polymorphism on BMD in men was also addressed. SUBJECTS: Eighty‐one Thai men aged 20–79 years. All were healthy and did not take medication which may affect calcium and bone metabolism. BMD was assessed by DEXA. Dietary calcium was assessed by a 3‐day dietary record. Serum E2 and FT concentrations were measured by radioimmunoassay. Polymorphism at intron 1 of the α isoform of ER gene was determined by PCR–RFLP. Small p represents the presence of the restriction site while capital P indicates the absence of the restriction site. RESULTS: Serum FT decreased with increasing age (r = −0.58, P < 0.0001) while E2 did not. However, there was a positive association between E2 and FT (r = 0.28, P < 0.05). Serum FT was related to BMD at femoral neck (r = 0.26, P < 0.05) and Ward's triangle (r = 0.30, P < 0.01) while E2 was related to BMD at anteroposterior (AP) lumbar spine (r = 0.29, P < 0.05), femoral neck (r = 0.23, P < 0.05) and femoral trochanter (r = 0.27, P < 0.05). Besides FT and E2, age, body weight, fat mass and fat‐free mass were also correlated to BMD at various skeletal sites. Using stepwise multiple linear regression to control for the confounding effects among these factors, fat‐free mass was found to be strongly associated with BMD at most skeletal sites. Serum E2 was related to BMD independently of other factors including FT at AP lumbar spine (r = 0.22, P < 0.05), femoral neck (r = 0.26, P < 0.01), femoral trochanter (r = 0.22, P < 0.05) and Ward's triangle (r = 0.26, P < 0.01) while serum FT was not associated with BMD at any site after controlling for E2 and other related factors. Concerning ERα gene polymorphism, 27 (33.3%) of the subjects had pp genotype, while 42 (51.9%) and 12 (14.8%) Pp and PP genotypes, respectively. After controlling for age, body weight, fat mass, fat‐free mass, calcium intake, FT and E2, the presence of P allele was associated with higher BMD at AP L2‐L4 (P < 0.05). CONCLUSIONS: Serum oestradiol is more related to bone mass than free testosterone in normal men. Oestrogen‐receptor gene polymorphism is also associated with bone mass in men independently of oestradiol levels. Serum oestradiol together with oestrogen‐receptor genotype may partly determine bone mass in males.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2265.1998.00631.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 22

  1. 10.1093/ajcn/63.3.365 · DOI
  2. 10.1002/jbmr.5650110818 · DOI
  3. 10.1002/jbmr.5650100112 · DOI
  4. 10.1093/oxfordjournals.aje.a116842 · DOI · Paper page
  5. 10.1210/jcem-71-5-1322 · DOI · Paper page
  6. 10.1210/endo-124-3-1576 · DOI · Paper page
  7. 10.1210/jcem-72-4-808 · DOI · Paper page
  8. 10.1136/bmj.300.6736.1361 · DOI · Paper page
  9. 10.1002/jbmr.5650110304 · DOI · Paper page
  10. Korach K.S., 1996, Oestrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes, Recent Progress in Hormone Research, 51, 159
  11. 10.1002/jbmr.5650080102 · DOI · Paper page
  12. 10.1002/jbmr.5650050614 · DOI · Paper page
  13. 10.1210/jc.80.12.3689 · DOI · Paper page
  14. 10.1111/j.1532-5415.1993.tb02049.x · DOI · Paper page
  15. 10.1038/367284a0 · DOI · Paper page
  16. 10.1016/S0169-6009(08)80022-0 · DOI · Paper page
  17. 10.1210/edrv-16-1-87 · DOI · Paper page
  18. 10.1002/jbmr.5650100904 · DOI · Paper page
  19. 10.1210/jc.75.3.779 · DOI · Paper page
  20. 10.1172/JCI110039 · DOI · Paper page
  21. 10.1172/JCI107476 · DOI · Paper page
  22. 10.1007/s002239900106 · DOI

Cited by

See all 174

Metadata

Authors
Ongphiphadhanakul, B., Rajatanavin, R., Chanprasertyothin, S., Piaseu, N., & Chailurkit, L.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
1998-12
Volume
49
Issue
6
Pages
803-809
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2044054235
Cited by
174
References
3
FWCI
11.87
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum oestradiol and oestrogen‐receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males. https://app.cochat.ai/papers/10.1046/j.1365-2265.1998.00631.x
The paper
Ongphiphadhanakul, B., Rajatanavin, R., Chanprasertyothin, S., Piaseu, N., & Chailurkit, L. (1998). Serum oestradiol and oestrogen‐receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.1998.00631.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.